Cargando…
Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study
BACKGROUND: A rare subtype of breast cancer, atypical medullary carcinoma of the breast (AMCB), shows a highly adverse prognosis compared to medullary carcinoma of the breast (MBC). The current study aimed to establish a correlated nomogram for the identification of the prognostic factors of AMCB an...
Autores principales: | Qin, Wenxing, Qi, Feng, Guo, Mengzhou, Wang, Liangzhe, Zang, Yuan-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290126/ https://www.ncbi.nlm.nih.gov/pubmed/34295817 http://dx.doi.org/10.3389/fonc.2021.677207 |
Ejemplares similares
-
Atypical presentation of renal medullary carcinoma: A case report and review of the literature
por: AL-Daghmin, Ali, et al.
Publicado: (2018) -
Design of new drugs for medullary thyroid carcinoma
por: Li, Yanqing, et al.
Publicado: (2022) -
Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
por: Tourigny, David S., et al.
Publicado: (2022) -
Hormone receptor status and survival of medullary breast cancer patients: A Turkish cohort
por: Aksoy, Asude, et al.
Publicado: (2017) -
Ceruloplasmin Status in Medullary Thyroid Carcinoma
por: RAZAVI, Fatemeh, et al.
Publicado: (2020)